Venture
Women in VC: MMV's Brunet on tech opportunities and navigating volatile markets
Alix Brunet speaks to Unquote about the VC firmтs deal pipeline and how it is engaging with portfolio companies and new founders
Newly launched Utopia Capital aims to deploy EUR 10m-plus by 2028
Angel investor Christian Schroeder's new investment vehicle will support early-stage tech companies addressing humanitarian issues
VC Profile: HTGF optimistic on seed stage opportunities as exit environment toughens
German seed investor secured almost EUR 500m for its fourth and biggest fund to date at a time when VC funding is slowing down
VC fundraising sinks further with lowest Q1 in a decade
Eight European firms secured just over EUR 2bn in commitments in Q1 2023 as continuing uncertainty suppresses LPsт risk appetite, but fundraising pipeline looks promising
VC Profile: Hi Inov in pre-marketing for next fund, outlines plans to wrap up Fund II investment period
France and Germany-based early-stage investor has made 15 of its up to 20 planned investments from its EUR 100m Fund II
Infravia aims to raise up to EUR 1bn for next growth fund, eyes mid-2024 launch
French sponsor expects to raise EUR 750m-EUR 1bn for B2B tech-focused second growth fund
VC Profile: Target Global assesses B2B opportunities in final stretch of current fund deployment
Nearing full deployment for its second growth fund, pan-European VC firm outlines plans to back defensive B2B models and institutionalise its co-investment strategy and LP base
EQT closes LSP Dementia on EUR 260m hard cap
Series A-focused fund exceeded its EUR 100m target and extended fundraising after increased LP interest in its strategy
Newton Biocapital heads for year-end close for second, EUR 150m life sciences fund
Belgian-Japanese VC has raised EUR 50m to date and is lining up exits from its debut fund
Sofinnova launches digital medicine strategy
Life sciences sponsorтs sixth strategy will deploy EUR 2m-EUR 8m tickets in seed and Series A
Nekko aims to reach EUR 10m hard-cap for N Venture I within six months
Spanish VC firm plans to build on the vehicle’s EUR 6m first close, with nine companies backed so far
GR Capital in 'active stage' of USD 50m-USD 70m fundraise
Berlin-based, Ukrainian-owned VC firm could invest up to USD 30m in 2023, targeting a range of technology subsectors
Euroventures scans CEE for tech-based B2B targets, plans new EUR 100m fund
Fundraising for Budapest-based sponsor's sixth fund is expected to start in H2 2024
Planet A raises EUR 160m for debut greentech fund
German VC will back scaleable hardware and software startups, giving science team "veto power" in investment decisions
Series A rounds likely bright spots in VC investing in Q1 2023 – KPMG
Energy security, ESG deals to continue apace, with consumer-focused businesses seeing most strain
Practica Capital aims for EUR 80m hard-cap for third fund
Lithuanian VC investor could hold second and final close in May or June next year
Highland Europe leads EUR 60m round for Le Collectionist
France-based luxury holiday company is aiming for market consolidation following the fresh funding
EQT closes Europe's largest VC fund with EUR 1.1bn raised
Registered in September, EQT Ventures III is almost double the size of its predecessor
Hambro Perks holds first close for debut venture debt fund
B2B software and patented hardware-focused fund is more than halfway towards its GBP 100m target
Startup Wise Guys gears up for B2B fund close next year
Estonian VC is targeting institutionals, family offices and HNWI for EUR 20m Challenger Fund II
Iris Ventures preps new fundraise as Fund I nears final close
Spanish firm's debut vehicle closes in on EUR 100m target; institutional LPs eyed for new fund
Fasanara targets USD 110m first close for new fund by year-end
UK-based investor in talks with institutional investors to close USD 350m VC vehicle in H1 2023
500 Emerging Europe set for EUR 70m fund close by year-end
Turkish VC’s second early-stage vehicle has so far received more than EUR 50m in commitments
Capricorn Partners seeks EUR 25m for industrial biotech VC fund
Belgian GP plans year-end final close after raising EUR 10m from InnovationQuarter and chemicals group DSM